Furadantin (nitrofurantoin), a synthetic chemical, is a stable, yellow, crystalline compound. Furadantin is an antibacterial agent for specific urinary tract infections.
Furadantin (nitrofurantoin) is specifically indicated for the treatment of urinary tract infections when due to susceptible strains of Escherichia coli, enterococci, Staphylococcus aureus, and certain susceptible strains of Klebsiella and Enterobacter species.
Nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses.
Nitrofurantoins lack the broader tissue distribution of other therapeutic agents approved for urinary tract infections. Consequently, many patients who are treated with Furadantin are predisposed to persistence or reappearance of bacteriuria. Urine specimens for culture and susceptibility testing should be obtained before and after completion of therapy. If persistence or reappearance of bacteriuria occurs after treatment with Furadantin, other therapeutic agents with broader tissue distribution should be selected. In considering the use of Furadantin, lower eradication rates should be balanced against the increased potential for systemic toxicity and for the development of antimicrobial resistance when agents with broader tissue distribution are utilized.
Media Articles Related to Furadantin (Nitrofurantoin)
Study: Antibiotic commonly prescribed for bladder infections less effective than others
Source: Urology / Nephrology News From Medical News Today [2015.04.28]
Older women with urinary tract infections who are taking the commonly prescribed antibiotic nitrofurantoin are more likely to experience treatment failure, resulting in a second antibiotic...
Published Studies Related to Furadantin (Nitrofurantoin)
One week of nitrofurantoin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. [2011.01]
CONCLUSIONS: Prophylaxis with NFT for a week before PNL is beneficial in the prevention of urosepsis and endotoxemia in patients with larger stones and HDN. NFT covers most of the urinary isolates and is preferred in areas of fluoroquinolone resistance. Copyright A(c) 2011 Elsevier Inc. All rights reserved.
One-day compared with 7-day nitrofurantoin for asymptomatic bacteriuria in pregnancy: a randomized controlled trial. [2009.02]
OBJECTIVE: To evaluate whether a 1-day nitrofurantoin regimen is as effective as a 7-day regimen in eradicating asymptomatic bacteriuria during pregnancy... CONCLUSION: A 1-day regimen of nitrofurantoin is significantly less effective than a 7-day regimen. Women with asymptomatic bacteriuria in pregnancy should receive the standard 7-day regimen. CLINICAL TRIAL REGISTRATION: ISRCTN, isrctn.org, ISRCTN11966080 LEVEL OF EVIDENCE: I.
Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. [2007.11.12]
BACKGROUND: There is a paucity of data on the efficacy of nitrofurantoin for the treatment of acute uncomplicated cystitis in regimens shorter than 7 days. Evidence-based use of this drug is increasingly important as trimethoprim-sulfamethoxazole resistance among uropathogens increases... CONCLUSION: A 5-day course of nitrofurantoin is equivalent clinically and microbiologically to a 3-day course of trimethoprim-sulfamethoxazole and should be considered an effective fluoroquinolone-sparing alternative for the treatment of acute cystitis in women.
A randomized, double-blind, placebo-controlled comparison of the effect of nitrofurantoin monohydrate macrocrystals on the development of urinary tract infections after surgery for pelvic organ prolapse and/or stress urinary incontinence with suprapubic catheterization. [2004.07]
OBJECTIVE: The purpose of this study was to determine if antibiotic prophylaxis with nitrofurantoin monohydrate macrocrystals (study drug) after pelvic organ prolapse and/or urinary incontinence surgery with suprapubic catheterization (SPC) decreases urinary tract infection (uti) compared with placebo in a randomized, double-blind, multicenter trial... CONCLUSION: Antibiotic prophylaxis with nitrofurantoin monohydrate macrocrystals decreases UTI compared with placebo after pelvic organ prolapse and/or urinary incontinence surgery with suprapubic catheterization.
Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women. [2003.06.01]
We compared the efficacy and safety of estriol-containing vaginal pessary use with those of oral nitrofurantoin macrocrystal (NM) therapy for preventing urinary tract infection (UTI) in postmenopausal women with recurrent UTI. Over a period of 9 months, 86 women received an estriol-containing vaginal pessary (0.5 mg estriol) twice weekly, and 85 women received NM (100 mg) once daily...
Clinical Trials Related to Furadantin (Nitrofurantoin)
Food Study of Nitrofurantoin Macrocrystals 100 mg Capsules and MacrodantinŽ 100 mg [Completed]
The objective of this study was to evaluate the relative bioavailability of Mylan's
nitrofurantoin macrocrystals 100 mg capsules to Procter & Gamble's MacrodantinŽ 100 mg
capsules following a single, oral 100 mg (1 x 100 mg) dose in 28 healthy, adult, non-tobacco
using volunteers under fed conditions.
Food Study of Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg and MacrobidŽ Capsules 100 mg [Completed]
The objective of this study was to investigate the bioequivalence of Mylan's nitrofurantoin
monohydrate/macrocrystals capsules to Procter & Gamble's MacrobidŽ capsules following a
single, oral 100 mg (1 x 100 mg) dose under fed conditions.
Short Course Nitrofurantoin for Acute Cystitis [Completed]
The purpose of this research study is to determine what the cure rates are with a 5 day
course of nitrofurantoin versus the more standard 3 day course of
trimethoprim/sulfamethoxazone. The study will improve our knowledge of which antibiotic and
what length of therapy is best for treatment of UTI, taking into account the problem of
Procedures subjects will undergo once they have read and signed the consent are:
Questions about their medical and sexual history and current symptoms of UTI. They will be
asked to provide a urine sample and then randomly assigned to one of the two treatment
will be obtained at each visit. If they were assigned to the nitrofurantoin treatment
regimen, they will also be asked to collect a urine sample at home on the third day. If the
subject develops recurrent urinary symptoms or does not have resolution of symptoms after
completing the initial treatment course, they will be asked to return to the clinic and
provide another urine sample for analysis. They will then be treated with another standard
antibiotic at no cost to them and will be withdrawn from the study at that time.
The study population is women ages 18-45 with acute symptoms of a UTI without a history of
UTI in the past 6 weeks.
Does Post-Operative Prophylaxis With Macrobid Reduce the Incidence of Post-Operative Urinary Tract Infection in Patients Undergoing Placement of a Sub-Urethral Sling for the Treatment of Stress Urinary Incontinence [Recruiting]
This project will be a randomized, double blinded, placebo controlled clinical trial. The
aim of the trial is to determine whether or not post-operative prophylaxis with macrobid
will decrease the incidence of postoperative urinary tract infection in women receiving
sub-urethral slings for the treatment of urinary incontinence.
Suppressive Therapy With Oral Antibiotics for Prevention of Postoperative Urinary Tract Infection (UTI) [Recruiting]
This is a study of patients undergoing gynecologic surgery who require post-operative
catheterization to determine if prophylactic antibiotic treatment decreases the risk of
post-operative urinary tract infection in these patients.
Reports of Suspected Furadantin (Nitrofurantoin) Side Effects
Colitis Microscopic (4),
Abdominal Pain (3),
Acute Generalised Exanthematous Pustulosis (3),
Pyrexia (2), more >>